InVivo Goes 2 For 2, Seeking Uplisting
Seeking Alpha
Submitted by moderatorj on Tue, 09/25/2012 - 21:14
InVivo Therapeutics Opens New Office and Labs in Cambridge, Massachusetts
Yahoo/BusinessWire
Submitted by moderatorj on Thu, 09/20/2012 - 22:57
InVivo CSO steps down after less than 1 year on the job | Personnel Moves
Submitted by moderatorj on Tue, 09/18/2012 - 22:58
InVivo Therapeutics Appoints Brian Hess as Interim Chief Science Officer
Yahoo/BusinessWire
Submitted by moderatorj on Mon, 08/13/2012 - 20:56
InVivo Therapeutics Neurosurgeon Receives MDHonors Grant For Applying Hydrogels to Spinal Cord Injury
Yahoo/BusinessWire
Submitted by moderatorj on Mon, 07/02/2012 - 16:28
InVivo targets $22B injectable pain-relief market | Regulatory Roundup
Submitted by moderatorj on Wed, 05/30/2012 - 22:15
InVivo snags Stryker spinal exec to breach chronic pain market | Personnel Moves
Submitted by admin on Tue, 05/15/2012 - 18:55
InVivo Therapeutics Reports First Quarter 2012 Financial Results, Provides Business Update
Submitted by moderatorj on Sat, 05/12/2012 - 12:28
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Submitted by moderatorj on Fri, 04/13/2012 - 17:55
InVivo Therapeutics Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries
Yahoo/BusinessWire